{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:12:46Z","timestamp":1789647166498,"version":"4.0.0"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T00:00:00Z","timestamp":1662249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ISRM\/12(41)\/2019"],"award-info":[{"award-number":["ISRM\/12(41)\/2019"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,13]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antimicrobial resistance in bacteria poses major challenges in selection of the therapeutic regime for managing the infectious disease. There is currently an upsurge in the appearance of multiple drug resistance in bacterial pathogens and a decline in the discovery of novel antibiotics. DNA gyrase is an attractive target used for antibiotic discovery due to its vital role in bacterial DNA replication and segregation in addition to its absence in mammalian organisms. Despite the presence of successful antibiotics targeting this enzyme, there is a need to bypass the resistance against this validated drug target. Hence, drug development in DNA gyrase is a highly active research area. In addition to the conventional binding sites for the novobiocin and fluoroquinolone antibiotics, several novel sites are being exploited for drug discovery. The binding sites for novel bacterial type II topoisomerase inhibitor (NBTI), simocyclinone, YacG, Thiophene and CcdB are structurally and biochemically validated active sites, which inhibit the supercoiling activity of topoisomerases. The novel chemical moieties with varied scaffolds have been identified to target DNA gyrase. Amongst them, the NBTI constitutes the most advanced DNA gyrase inhibitor which are in phase III trial of drug development.<\/jats:p><jats:p>The present review aims to classify the novel binding sites other than the conventional novobiocin and quinolone binding pocket to bypass the resistance due to mutations in the DNA gyrase enzyme. These sites can be exploited for the identification of new scaffolds for the development of novel antibacterial compounds.<\/jats:p>","DOI":"10.1093\/bfgp\/elac029","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T02:38:58Z","timestamp":1662431938000},"page":"180-194","source":"Crossref","is-referenced-by-count":48,"title":["Targeting novel sites in DNA gyrase for development of anti-microbials"],"prefix":"10.1093","volume":"22","author":[{"given":"Mohd","family":"Salman","sequence":"first","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences , New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences , New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences , New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S","family":"Ethayathulla","sequence":"additional","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences , New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7358-3716","authenticated-orcid":false,"given":"Punit","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences , New Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,4]]},"reference":[{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"The Lancet"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/ijmm.IJMM_17_412","article-title":"Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade","volume":"36","author":"Sharma","year":"2018","journal-title":"Indian J Med Microbiol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/jac\/dkl110","article-title":"Fluoroquinolone resistance and plasmid addiction systems: self-imposed selection pressure?","volume":"57","author":"Ellington","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","article-title":"Antibiotics: past, present and future","volume":"51","author":"Hutchings","year":"2019","journal-title":"Curr Opin Microbiol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3201\/eid2711.210726","article-title":"Genomic profiling of Mycobacterium tuberculosis strains, Myanmar","volume":"27","author":"Aung","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1473-3099(11)70316-4","article-title":"The crisis of no new antibiotics\u2014what is the way forward?","volume":"12","author":"Piddock","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.3390\/app10134629","article-title":"Multi-omics technologies applied to tuberculosis drug discovery","volume":"10","author":"Goff","year":"2020","journal-title":"Appl Sci"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-28916-7","article-title":"An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets","volume":"8","author":"Ramos","year":"2018","journal-title":"Sci Rep"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10529-017-2319-0","article-title":"Transcriptomics as a tool to discover new antibacterial targets","volume":"39","author":"Dom\u00ednguez","year":"2017","journal-title":"Biotechnol Lett"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ja.2015.98","article-title":"A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics","volume":"69","author":"Renwick","year":"2016","journal-title":"J Antibiot"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"104244","DOI":"10.1016\/j.bioorg.2020.104244","article-title":"Structure based drug discovery and in vitro activity testing for DNA gyrase inhibitors of Salmonella enterica serovar Typhi","volume":"104","author":"Sharma","year":"2020","journal-title":"Bioorg Chem"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1099\/00221287-132-9-2571","article-title":"Effect of DNA gyrase inhibitors and urea on the expression of cysB, the regulatory gene of the cysteine regulon","volume":"132","author":"Bieli\u0144ska","year":"1986","journal-title":"Microbiology"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fmicb.2019.00249","article-title":"Genome-wide transcriptional responses of Mycobacterium to antibiotics","volume":"10","author":"Briffotaux","year":"2019","journal-title":"Front Microbiol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12551-016-0240-8","article-title":"The dynamic interplay between DNA topoisomerases and DNA topology","volume":"8","author":"Seol","year":"2016","journal-title":"Biophys Rev"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu Rev Biochem"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0163-7258(89)90108-3","article-title":"Biochemical basis for the interactions of type I and type II topoisomerases with DNA","volume":"41","author":"Osheroff","year":"1989","journal-title":"Pharmacol Ther"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10409239109114072","article-title":"DNA gyrase: structure and function","volume":"26","author":"Reece","year":"1991","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/nar\/30.3.794","article-title":"An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani","volume":"30","author":"Das","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"e41215","DOI":"10.7554\/eLife.41215","article-title":"CryoEM structures of open dimers of gyrase a in complex with DNA illuminate mechanism of strand passage","volume":"7","author":"Soczek","year":"2018","journal-title":"Elife"},{"key":"2023041318221930800_","article-title":"Genome analyses of 174 strains of Mycobacterium tuberculosis provide insight into the evolution of drug resistance and reveal potential drug targets","volume":"7","author":"Verma","year":"2021","journal-title":"Microb Genom"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/j.1460-2075.1996.tb00483.x","article-title":"The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography","volume":"15","author":"Lewis","year":"1996","journal-title":"EMBO J"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.1179123","article-title":"A crystal structure of the bifunctional antibiotic simocyclinone D8, bound to DNA gyrase","volume":"326","author":"Edwards","year":"2009","journal-title":"Science"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J Pathol: J Pathol Soc Great Britain Ireland"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"e0126560","DOI":"10.1371\/journal.pone.0126560","article-title":"Structure based in silico analysis of quinolone resistance in clinical isolates of Salmonella Typhi from India","volume":"10","author":"Kumar","year":"2015","journal-title":"PLoS One"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/infdis\/174.5.1127","article-title":"Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis","volume":"174","author":"Xu","year":"1996","journal-title":"J Infect Dis"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"e39754","DOI":"10.1371\/journal.pone.0039754","article-title":"New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations","volume":"7","author":"Malik","year":"2012","journal-title":"PLoS One"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coph.2014.09.007","article-title":"Novel compounds targeting bacterial DNA topoisomerase\/DNA gyrase","volume":"18","author":"Ehmann","year":"2014","journal-title":"Curr Opin Pharmacol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: current state and perspectives","volume":"92","author":"Collin","year":"2011","journal-title":"Appl Microbiol Biotechnol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.jmb.2019.07.008","article-title":"DNA topoisomerase inhibitors: trapping a DNA-cleaving machine in motion","volume":"431","author":"Bax","year":"2019","journal-title":"J Mol Biol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1021\/acs.jmedchem.8b01928","article-title":"Structural basis for DNA gyrase interaction with coumermycin A1","volume":"62","author":"Vanden Broeck","year":"2019","journal-title":"J Med Chem"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"e107289","DOI":"10.1371\/journal.pone.0107289","article-title":"Structure of the N-terminal gyrase B fragment in complex with ADP\u00b7 Pi reveals rigid-body motion induced by ATP hydrolysis","volume":"9","author":"Stanger","year":"2014","journal-title":"PLoS One"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/42294","article-title":"Crystal structure of the breakage\u2013reunion domain of DNA gyrase","volume":"388","author":"Cabral","year":"1997","journal-title":"Nature"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-64792-w","article-title":"The pivot point arginines identified in the \u03b2-pinwheel structure of C-terminal domain from salmonella Typhi DNA gyrase A subunit","volume":"10","author":"Sachdeva","year":"2020","journal-title":"Sci Rep"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"101000","DOI":"10.1016\/j.jbc.2021.101000","article-title":"Basic residues at the C-gate of DNA gyrase are involved in DNA supercoiling","volume":"297","author":"Smith","year":"2021","journal-title":"J Biol Chem"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"9468","DOI":"10.1074\/jbc.275.13.9468","article-title":"Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center","volume":"275","author":"Brino","year":"2000","journal-title":"J Biol Chem"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"108786","DOI":"10.1016\/j.abb.2021.108786","article-title":"Structural insights into the transient closed conformation and pH dependent ATPase activity of S. Typhi Gyrase B N-terminal domain","volume":"701","author":"Gupta","year":"2021","journal-title":"Arch Biochem Biophys"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jmb.2016.03.016","article-title":"Structural dynamics and mechanochemical coupling in DNA gyrase","volume":"428","author":"Basu","year":"2016","journal-title":"J Mol Biol"},{"key":"2023041318221930800_","first-page":"1","article-title":"DNA gyrase inhibitors","author":"Khan","year":"2021","journal-title":"Encycl Mol Pharmacol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1568026613666131113150046","article-title":"Designing type II topoisomerase inhibitors: a molecular modeling approach","volume":"14","author":"Perez","year":"2014","journal-title":"Curr Top Med Chem"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nature08974","article-title":"A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases","volume":"465","author":"Schmidt","year":"2010","journal-title":"Nature"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/nar\/gkp024","article-title":"Effects of magnesium and related divalent metal ions in topoisomerase structure and function","volume":"37","author":"Sissi","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3390\/antibiotics10121506","article-title":"Delafloxacin, finafloxacin, and zabofloxacin: novel fluoroquinolones in the antibiotic pipeline","volume":"10","author":"Kocsis","year":"2021","journal-title":"Antibiotics"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"100017","DOI":"10.1016\/j.ejmcr.2021.100017","article-title":"Novel bacterial topoisomerase inhibitors (NBTIs)\u2013a comprehensive review","volume":"3","author":"Desai","year":"2021","journal-title":"Eur J Medicinal Chem Rep"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1021\/bi0159837","article-title":"DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5 \u2018-methyl group of the noviose","volume":"41","author":"Lafitte","year":"2002","journal-title":"Biochemistry"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1021\/cb5001197","article-title":"Structures of kibdelomycin bound to Staphylococcus aureus GyrB and ParE showed a novel U-shaped binding mode","volume":"9","author":"Lu","year":"2014","journal-title":"ACS Chem Biol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1093\/jac\/dkaa286","article-title":"Structural and mechanistic analysis of ATPase inhibitors targeting mycobacterial DNA gyrase","volume":"75","author":"Henderson","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1021\/bi970294+","article-title":"The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study","volume":"36","author":"Holdgate","year":"1997","journal-title":"Biochemistry"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.1525047113","article-title":"Crystal structure and stability of gyrase\u2013fluoroquinolone cleaved complexes from Mycobacterium tuberculosis","volume":"113","author":"Blower","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"e11338","DOI":"10.1371\/journal.pone.0011338","article-title":"Structural basis of gate-DNA breakage and resealing by type II topoisomerases","volume":"5","author":"Laponogov","year":"2010","journal-title":"PLoS One"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20405-8","article-title":"Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds","volume":"12","author":"Kolari\u010d","year":"2021","journal-title":"Nat Commun"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1021\/acsinfecdis.8b00315","article-title":"Mechanistic and structural basis for the actions of the antibacterial gepotidacin against Staphylococcus aureus gyrase","volume":"5","author":"Gibson","year":"2019","journal-title":"ACS Infect Dis"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1016\/j.bmcl.2013.07.013","article-title":"Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases","volume":"23","author":"Miles","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.jmb.2014.02.017","article-title":"A new crystal structure of the bifunctional antibiotic simocyclinone D8 bound to DNA gyrase gives fresh insight into the mechanism of inhibition","volume":"426","author":"Hearnshaw","year":"2014","journal-title":"J Mol Biol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1101\/gad.241984.114","article-title":"Direct control of type IIA topoisomerase activity by a chromosomally encoded regulatory protein","volume":"28","author":"Vos","year":"2014","journal-title":"Genes Dev"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jmb.2005.03.049","article-title":"Molecular basis of gyrase poisoning by the addiction toxin CcdB","volume":"348","author":"Dao-Thi","year":"2005","journal-title":"J Mol Biol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2958.2012.08069.x","article-title":"Alternative interactions define gyrase specificity in the CcdB family","volume":"84","author":"De Jonge","year":"2012","journal-title":"Mol Microbiol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1006\/jmbi.1998.2395","article-title":"Crystal structure of CcdB, a topoisomerase poison from E. coli 1 1Edited by T. Richmond","volume":"285","author":"Loris","year":"1999","journal-title":"J Mol Biol"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"E4492","DOI":"10.1073\/pnas.1700721114","article-title":"Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase","volume":"114","author":"Chan","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2174\/092986707781368414","article-title":"Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents","volume":"14","author":"Oblak","year":"2007","journal-title":"Curr Med Chem"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1128\/AAC.44.11.3040-3048.2000","article-title":"Identification of the coumermycin A1Biosynthetic gene cluster of Streptomyces rishiriensis DSM 40489","volume":"44","author":"Wang","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/jac\/dkr247","article-title":"Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics","volume":"66","author":"Alt","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/dkg208","article-title":"The quinolones: decades of development and use","volume":"51","author":"Emmerson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-64934-0","article-title":"Genomic profiling of antimicrobial resistance genes in clinical isolates of Salmonella Typhi from patients infected with typhoid fever in India","volume":"10","author":"Katiyar","year":"2020","journal-title":"Sci Rep"},{"key":"2023041318221930800_","first-page":"687","article-title":"Pefloxacin as a surrogate marker for quinolone susceptibility in Salmonella enterica serovars Typhi & Paratyphi A in India","volume":"145","author":"Sharma","year":"2017","journal-title":"Indian J Med Res"},{"key":"2023041318221930800_","first-page":"43","article-title":"Study of mutations in the DNA gyrase gyrA gene of Escherichia coli","volume":"9","author":"Jaktaji","year":"2010","journal-title":"Iran J Pharmaceut Res: IJPR"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/ijmm.IJMM_16_382","article-title":"Characterisation of antimicrobial resistance in Salmonellae during 2014\u20132015 from four centres across India: an ICMR antimicrobial resistance surveillance network report","volume":"35","author":"Dahiya","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"2023041318221930800_","first-page":"455","article-title":"The molecular genetics of fluoroquinolone resistance in Mycobacterium tuberculosis","volume":"2","author":"Mayer","year":"2014","journal-title":"Mol Genet Mycobacteria"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1128\/AAC.01321-06","article-title":"In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase\/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups","volume":"51","author":"Huband","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7164\/antibiotics.53.779","article-title":"Simocyclinones, novel cytostatic angucyclinone antibiotics produced by Streptomyces antibioticus T\u00fc 6040 I. taxonomy, fermentation, isolation and biological activities","volume":"53","author":"Schimana","year":"2000","journal-title":"J Antibiot"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"fux055","DOI":"10.1093\/femsre\/fux055","article-title":"Structural insights into simocyclinone as an antibiotic, effector ligand and substrate","volume":"42","author":"Buttner","year":"2018","journal-title":"FEMS Microbiol Rev"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1128\/AAC.49.3.1093-1100.2005","article-title":"Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action","volume":"49","author":"Flatman","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2023041318221930800_","first-page":"01492","article-title":"Dose selection for phase III clinical evaluation of Gepotidacin (GSK2140944) in the treatment of uncomplicated urinary tract infections","volume":"AAC","author":"Scangarella-Oman","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1093\/nar\/gkn355","article-title":"YacG from Escherichia coli is a specific endogenous inhibitor of DNA gyrase","volume":"36","author":"Sengupta","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/nar\/29.8.1703","article-title":"Treble clef finger\u2014a functionally diverse zinc-binding structural motif","volume":"29","author":"Grishin","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/nar\/gkg161","article-title":"Structural classification of zinc fingers: survey and summary","volume":"31","author":"Krishna","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.str.2019.01.004","article-title":"Overall structures of Mycobacterium tuberculosis DNA gyrase reveal the role of a corynebacteriales GyrB-specific insert in ATPase activity","volume":"27","author":"Petrella","year":"2019","journal-title":"Structure"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1073\/pnas.80.15.4784","article-title":"Mini-F plasmid genes that couple host cell division to plasmid proliferation","volume":"80","author":"Ogura","year":"1983","journal-title":"Proc Natl Acad Sci"},{"key":"2023041318221930800_","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.tibs.2005.10.004","article-title":"Toxin\u2013antitoxin modules as bacterial metabolic stress managers","volume":"30","author":"Buts","year":"2005","journal-title":"Trends Biochem Sci"}],"container-title":["Briefings in Functional Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bfg\/article-pdf\/22\/2\/180\/49873636\/elac029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bfg\/article-pdf\/22\/2\/180\/49873636\/elac029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T04:14:22Z","timestamp":1700972062000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bfg\/article\/22\/2\/180\/6691738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,4]]},"references-count":80,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,9,4]]},"published-print":{"date-parts":[[2023,4,13]]}},"URL":"https:\/\/doi.org\/10.1093\/bfgp\/elac029","relation":{},"ISSN":["2041-2649","2041-2657"],"issn-type":[{"value":"2041-2649","type":"print"},{"value":"2041-2657","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3]]},"published":{"date-parts":[[2022,9,4]]}}}